Literature DB >> 17242936

The frequency of C3435T MDR1 gene polymorphism in Iranian patients with ulcerative colitis.

Alma Farnood1, Nosratollah Naderi, Seyed Javad Mirhasani Moghaddam, Babak Noorinayer, Farzad Firouzi, Rahim Aghazadeh, Nasser Ebrahimi daryani, Mohammad Reza Zali.   

Abstract

BACKGROUND AND AIMS: The MDR1 (multidrug resistance) gene, located on chromosome 7, is in one of the inflammatory bowel disease susceptibility loci. It produces P-glycoprotein, a transmembrane efflux pump, transferring drugs and toxins from intracellular to extracellular domains. In the human gastrointestinal (GI) tract, P-glycoprotein is found in high concentrations on the epithelial cells of the colon and small intestine. MDR1 gene polymorphisms such as C3435T are associated with lower P-glycoprotein expression, and thus it is suggested to have an association with ulcerative colitis. We tried to determine the frequency of C3435T polymorphism of the MDR1 gene in Iranian patients with ulcerative colitis and to compare it with a healthy control population.
MATERIALS AND METHODS: In this case-control-designed study, 300 unrelated ulcerative colitis patients and 300 sex-and-age-matched healthy controls were enrolled. They were visited at a tertiary center during a 2-year period (2003-2005). DNA of patients and controls was amplified by polymerase chain reaction with specific primers, and C3435T polymorphism was detected by the restriction fragment length polymorphism method.
RESULTS: The frequency of the 3435T allele was significantly higher in ulcerative colitis patients compared to the controls (p < 0.001). The frequency of homozygote T/T and heterozygote C/T genotypes were also significantly higher in Iranian patients with ulcerative colitis (p = 0.044 and 0.041, respectively).
CONCLUSION: This study suggests that C3435T polymorphism of the MDR1 gene has an association with ulcerative colitis in Iranian population as previously reported in western countries.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17242936     DOI: 10.1007/s00384-007-0270-6

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  31 in total

Review 1.  Inflammatory bowel disease.

Authors:  Daniel K Podolsky
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

2.  MDR1 gene polymorphism in ulcerative colitis.

Authors:  Jürgen Glas; Helga-Paula Török; Uwe Schiemann; Christian Folwaczny
Journal:  Gastroenterology       Date:  2004-01       Impact factor: 22.682

3.  Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects.

Authors:  I Cascorbi; T Gerloff; A Johne; C Meisel; S Hoffmeyer; M Schwab; E Schaeffeler; M Eichelbaum; U Brinkmann; I Roots
Journal:  Clin Pharmacol Ther       Date:  2001-03       Impact factor: 6.875

4.  Differences in P-glycoprotein-170 expression and activity between Crohn's disease and ulcerative colitis.

Authors:  B Yacyshyn; W Maksymowych; M B Bowen-Yacyshyn
Journal:  Hum Immunol       Date:  1999-08       Impact factor: 2.850

5.  Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn disease and ulcerative colitis.

Authors:  U Potocnik; I Ferkolj; D Glavac; M Dean
Journal:  Genes Immun       Date:  2004-11       Impact factor: 2.676

6.  Variable expression of P-glycoprotein in the human placenta and its association with mutations of the multidrug resistance 1 gene (MDR1, ABCB1).

Authors:  Monika Hitzl; Elke Schaeffeler; Berthold Hocher; Torsten Slowinski; Horst Halle; Michel Eichelbaum; Peter Kaufmann; Peter Fritz; Martin F Fromm; Matthias Schwab
Journal:  Pharmacogenetics       Date:  2004-05

7.  Clinical relationship between MDR1 gene and gallbladder cancer.

Authors:  Bai-Lin Wang; Hai-Ying Zhai; Bing-Yi Chen; Shu-Ping Zhai; Hai-Yan Yang; Xiao-Ping Chen; Wen-Tao Zhao; Lei Meng
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2004-05

Review 8.  Clinical aspects of the MDR1 (ABCB1) gene polymorphism.

Authors:  Michel Eichelbaum; Martin F Fromm; Matthias Schwab
Journal:  Ther Drug Monit       Date:  2004-04       Impact factor: 3.681

Review 9.  Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance.

Authors:  Catia Marzolini; Erik Paus; Thierry Buclin; Richard B Kim
Journal:  Clin Pharmacol Ther       Date:  2004-01       Impact factor: 6.875

Review 10.  The MDR1 (ABCB1) gene polymorphism and its clinical implications.

Authors:  Ichiro Ieiri; Hiroshi Takane; Kenji Otsubo
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

View more
  27 in total

1.  NOD2 exonic variations in Iranian Crohn's disease patients.

Authors:  Nosratollah Naderi; Alma Farnood; Manijeh Habibi; Homayoun Zojaji; Hedieh Balaii; Farzad Firouzi; Mohsen Chiani; Faramarz Derakhshan; Ali Tahami; Rahim Aghazadeh; Nasser Ebrahimi Daryani; Mohammad Reza Zali
Journal:  Int J Colorectal Dis       Date:  2011-01-28       Impact factor: 2.571

2.  ABCB1 3435C>T and 2677G>T/A polymorphisms in Polish and Bosnian patients with Crohn's disease - A preliminary report.

Authors:  Krzysztof Borecki; Iwona Zawada; Anna Pawinska-Matecka; Nermin Nusret Salkic; Beata Karakiewicz; Grażyna Adler
Journal:  Bosn J Basic Med Sci       Date:  2017-11-20       Impact factor: 3.363

Review 3.  CTLA-4 and MDR1 polymorphisms increase the risk for ulcerative colitis: A meta-analysis.

Authors:  Jia-Jun Zhao; Di Wang; Hui Yao; Da-Wei Sun; Hong-Yu Li
Journal:  World J Gastroenterol       Date:  2015-09-14       Impact factor: 5.742

4.  Polymorphism C3435T of the MDR1 gene in Central Americans and Spaniards.

Authors:  J Vicente; Blanca Sinues; A Fanlo; P Vasquez; J C Medina; B Martinez-Jarreta
Journal:  Mol Biol Rep       Date:  2007-06-19       Impact factor: 2.316

5.  Effect of the C3435T polymorphism of the multidrug resistance 1 gene on the severity of inflammatory bowel disease in Iranian Azeri Turks.

Authors:  Mortaza J Bonyadi; Sousan M Gerami; Mohammad H Somi; Manouchehr Khoshbaten
Journal:  Saudi J Gastroenterol       Date:  2013 Jul-Aug       Impact factor: 2.485

6.  Multi-drug resistance 1 genetic polymorphism and prediction of chemotherapy response in Hodgkin's Lymphoma.

Authors:  Nizar M Mhaidat; Osama Y Alshogran; Omar F Khabour; Karem H Alzoubi; Ismail I Matalka; William J Haddadin; Ibraheem O Mahasneh; Ahmad N Aldaher
Journal:  J Exp Clin Cancer Res       Date:  2011-07-16

7.  Association of Tumor Necrosis Factor Alpha Gene Polymorphisms with Inflammatory Bowel Disease in Iran.

Authors:  Nosratollah Naderi; Alma Farnood; Tahereh Dadaei; Manijeh Habibi; Hedie Balaii; Farzad Firouzi; Aydin Mahban; Masoumeh Soltani; Mohammadreza Zali
Journal:  Iran J Public Health       Date:  2014-05       Impact factor: 1.429

8.  Can the prevalence of symptoms in patients with inflammatory bowel disease be predicted by the analysis of multidrug resistance gene 1 polymorphisms?

Authors:  Miguel Angel Chiurillo
Journal:  Saudi J Gastroenterol       Date:  2013 Jul-Aug       Impact factor: 2.485

Review 9.  Epidemiology of inflammatory bowel diseases in iran and Asia; a mini review.

Authors:  Ali Reza Safarpour; Seyed Vahid Hosseini; Davood Mehrabani
Journal:  Iran J Med Sci       Date:  2013-06

10.  Determination of Vitamin D Serum Levels and Status of the C3435T Polymorphism of Multidrug Resistance 1 Gene in Southeastern Iranian Patients with Ulcerative Colitis.

Authors:  Mojgan Mohammadi; Mohammad Javad Zahedi; Amin Reza Nikpoor; Mehdi Nazem; Payam Khazaeli; Mohammad Mahdi Hayatbakhsh
Journal:  Middle East J Dig Dis       Date:  2015-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.